Oolong Tea
The research report includes specific segments by region (country), by company, by Type and by Ap ... Read More
Global Onychomycosis Market Research Report 2023
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Onychomycosis Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Distal Subungual Onychomycosis
1.2.3 White Superficial Onychomycosis
1.2.4 Proximal Subungual Onychomycosis
1.2.5 Candida Onychomycosis
1.2.6 Others
1.3 Market by Application
1.3.1 Global Onychomycosis Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Onychomycosis Market Perspective (2017-2028)
2.2 Onychomycosis Growth Trends by Region
2.2.1 Onychomycosis Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Onychomycosis Historic Market Size by Region (2017-2022)
2.2.3 Onychomycosis Forecasted Market Size by Region (2023-2028)
2.3 Onychomycosis Market Dynamics
2.3.1 Onychomycosis Industry Trends
2.3.2 Onychomycosis Market Drivers
2.3.3 Onychomycosis Market Challenges
2.3.4 Onychomycosis Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Onychomycosis Players by Revenue
3.1.1 Global Top Onychomycosis Players by Revenue (2017-2022)
3.1.2 Global Onychomycosis Revenue Market Share by Players (2017-2022)
3.2 Global Onychomycosis Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Onychomycosis Revenue
3.4 Global Onychomycosis Market Concentration Ratio
3.4.1 Global Onychomycosis Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Onychomycosis Revenue in 2021
3.5 Onychomycosis Key Players Head office and Area Served
3.6 Key Players Onychomycosis Product Solution and Service
3.7 Date of Enter into Onychomycosis Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Onychomycosis Breakdown Data by Type
4.1 Global Onychomycosis Historic Market Size by Type (2017-2022)
4.2 Global Onychomycosis Forecasted Market Size by Type (2023-2028)
5 Onychomycosis Breakdown Data by Application
5.1 Global Onychomycosis Historic Market Size by Application (2017-2022)
5.2 Global Onychomycosis Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Onychomycosis Market Size (2017-2028)
6.2 North America Onychomycosis Market Size by Country (2017-2022)
6.3 North America Onychomycosis Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Onychomycosis Market Size (2017-2028)
7.2 Europe Onychomycosis Market Size by Country (2017-2022)
7.3 Europe Onychomycosis Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Onychomycosis Market Size (2017-2028)
8.2 Asia-Pacific Onychomycosis Market Size by Country (2017-2022)
8.3 Asia-Pacific Onychomycosis Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Onychomycosis Market Size (2017-2028)
9.2 Latin America Onychomycosis Market Size by Country (2017-2022)
9.3 Latin America Onychomycosis Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Onychomycosis Market Size (2017-2028)
10.2 Middle East & Africa Onychomycosis Market Size by Country (2017-2022)
10.3 Middle East & Africa Onychomycosis Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Detail
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Onychomycosis Introduction
11.1.4 Abbott Laboratories Revenue in Onychomycosis Business (2017-2022)
11.1.5 Abbott Laboratories Recent Development
11.2 Glaxosmithkline
11.2.1 Glaxosmithkline Company Detail
11.2.2 Glaxosmithkline Business Overview
11.2.3 Glaxosmithkline Onychomycosis Introduction
11.2.4 Glaxosmithkline Revenue in Onychomycosis Business (2017-2022)
11.2.5 Glaxosmithkline Recent Development
11.3 Pfizer
11.3.1 Pfizer Company Detail
11.3.2 Pfizer Business Overview
11.3.3 Pfizer Onychomycosis Introduction
11.3.4 Pfizer Revenue in Onychomycosis Business (2017-2022)
11.3.5 Pfizer Recent Development
11.4 Bausch Health
11.4.1 Bausch Health Company Detail
11.4.2 Bausch Health Business Overview
11.4.3 Bausch Health Onychomycosis Introduction
11.4.4 Bausch Health Revenue in Onychomycosis Business (2017-2022)
11.4.5 Bausch Health Recent Development
11.5 Galderma
11.5.1 Galderma Company Detail
11.5.2 Galderma Business Overview
11.5.3 Galderma Onychomycosis Introduction
11.5.4 Galderma Revenue in Onychomycosis Business (2017-2022)
11.5.5 Galderma Recent Development
11.6 Janssen Biotech
11.6.1 Janssen Biotech Company Detail
11.6.2 Janssen Biotech Business Overview
11.6.3 Janssen Biotech Onychomycosis Introduction
11.6.4 Janssen Biotech Revenue in Onychomycosis Business (2017-2022)
11.6.5 Janssen Biotech Recent Development
11.7 Bristol Meyer Squibb
11.7.1 Bristol Meyer Squibb Company Detail
11.7.2 Bristol Meyer Squibb Business Overview
11.7.3 Bristol Meyer Squibb Onychomycosis Introduction
11.7.4 Bristol Meyer Squibb Revenue in Onychomycosis Business (2017-2022)
11.7.5 Bristol Meyer Squibb Recent Development
11.8 Topica Pharmaceuticals
11.8.1 Topica Pharmaceuticals Company Detail
11.8.2 Topica Pharmaceuticals Business Overview
11.8.3 Topica Pharmaceuticals Onychomycosis Introduction
11.8.4 Topica Pharmaceuticals Revenue in Onychomycosis Business (2017-2022)
11.8.5 Topica Pharmaceuticals Recent Development
11.9 Sanofi
11.9.1 Sanofi Company Detail
11.9.2 Sanofi Business Overview
11.9.3 Sanofi Onychomycosis Introduction
11.9.4 Sanofi Revenue in Onychomycosis Business (2017-2022)
11.9.5 Sanofi Recent Development
11.10 Novartis
11.10.1 Novartis Company Detail
11.10.2 Novartis Business Overview
11.10.3 Novartis Onychomycosis Introduction
11.10.4 Novartis Revenue in Onychomycosis Business (2017-2022)
11.10.5 Novartis Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Onychomycosis Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of Distal Subungual Onychomycosis
Table 3. Key Players of White Superficial Onychomycosis
Table 4. Key Players of Proximal Subungual Onychomycosis
Table 5. Key Players of Candida Onychomycosis
Table 6. Key Players of Others
Table 7. Global Onychomycosis Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 8. Global Onychomycosis Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 9. Global Onychomycosis Market Size by Region (2017-2022) & (US$ Million)
Table 10. Global Onychomycosis Market Share by Region (2017-2022)
Table 11. Global Onychomycosis Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 12. Global Onychomycosis Market Share by Region (2023-2028)
Table 13. Onychomycosis Market Trends
Table 14. Onychomycosis Market Drivers
Table 15. Onychomycosis Market Challenges
Table 16. Onychomycosis Market Restraints
Table 17. Global Onychomycosis Revenue by Players (2017-2022) & (US$ Million)
Table 18. Global Onychomycosis Market Share by Players (2017-2022)
Table 19. Global Top Onychomycosis Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Onychomycosis as of 2021)
Table 20. Ranking of Global Top Onychomycosis Companies by Revenue (US$ Million) in 2021
Table 21. Global 5 Largest Players Market Share by Onychomycosis Revenue (CR5 and HHI) & (2017-2022)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Onychomycosis Product Solution and Service
Table 24. Date of Enter into Onychomycosis Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Onychomycosis Market Size by Type (2017-2022) & (US$ Million)
Table 27. Global Onychomycosis Revenue Market Share by Type (2017-2022)
Table 28. Global Onychomycosis Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 29. Global Onychomycosis Revenue Market Share by Type (2023-2028)
Table 30. Global Onychomycosis Market Size by Application (2017-2022) & (US$ Million)
Table 31. Global Onychomycosis Revenue Market Share by Application (2017-2022)
Table 32. Global Onychomycosis Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 33. Global Onychomycosis Revenue Market Share by Application (2023-2028)
Table 34. North America Onychomycosis Market Size by Country (2017-2022) & (US$ Million)
Table 35. North America Onychomycosis Market Size by Country (2023-2028) & (US$ Million)
Table 36. Europe Onychomycosis Market Size by Country (2017-2022) & (US$ Million)
Table 37. Europe Onychomycosis Market Size by Country (2023-2028) & (US$ Million)
Table 38. Asia-Pacific Onychomycosis Market Size by Region (2017-2022) & (US$ Million)
Table 39. Asia-Pacific Onychomycosis Market Size by Region (2023-2028) & (US$ Million)
Table 40. Latin America Onychomycosis Market Size by Country (2017-2022) & (US$ Million)
Table 41. Latin America Onychomycosis Market Size by Country (2023-2028) & (US$ Million)
Table 42. Middle East & Africa Onychomycosis Market Size by Country (2017-2022) & (US$ Million)
Table 43. Middle East & Africa Onychomycosis Market Size by Country (2023-2028) & (US$ Million)
Table 44. Abbott Laboratories Company Detail
Table 45. Abbott Laboratories Business Overview
Table 46. Abbott Laboratories Onychomycosis Product
Table 47. Abbott Laboratories Revenue in Onychomycosis Business (2017-2022) & (US$ Million)
Table 48. Abbott Laboratories Recent Development
Table 49. Glaxosmithkline Company Detail
Table 50. Glaxosmithkline Business Overview
Table 51. Glaxosmithkline Onychomycosis Product
Table 52. Glaxosmithkline Revenue in Onychomycosis Business (2017-2022) & (US$ Million)
Table 53. Glaxosmithkline Recent Development
Table 54. Pfizer Company Detail
Table 55. Pfizer Business Overview
Table 56. Pfizer Onychomycosis Product
Table 57. Pfizer Revenue in Onychomycosis Business (2017-2022) & (US$ Million)
Table 58. Pfizer Recent Development
Table 59. Bausch Health Company Detail
Table 60. Bausch Health Business Overview
Table 61. Bausch Health Onychomycosis Product
Table 62. Bausch Health Revenue in Onychomycosis Business (2017-2022) & (US$ Million)
Table 63. Bausch Health Recent Development
Table 64. Galderma Company Detail
Table 65. Galderma Business Overview
Table 66. Galderma Onychomycosis Product
Table 67. Galderma Revenue in Onychomycosis Business (2017-2022) & (US$ Million)
Table 68. Galderma Recent Development
Table 69. Janssen Biotech Company Detail
Table 70. Janssen Biotech Business Overview
Table 71. Janssen Biotech Onychomycosis Product
Table 72. Janssen Biotech Revenue in Onychomycosis Business (2017-2022) & (US$ Million)
Table 73. Janssen Biotech Recent Development
Table 74. Bristol Meyer Squibb Company Detail
Table 75. Bristol Meyer Squibb Business Overview
Table 76. Bristol Meyer Squibb Onychomycosis Product
Table 77. Bristol Meyer Squibb Revenue in Onychomycosis Business (2017-2022) & (US$ Million)
Table 78. Bristol Meyer Squibb Recent Development
Table 79. Topica Pharmaceuticals Company Detail
Table 80. Topica Pharmaceuticals Business Overview
Table 81. Topica Pharmaceuticals Onychomycosis Product
Table 82. Topica Pharmaceuticals Revenue in Onychomycosis Business (2017-2022) & (US$ Million)
Table 83. Topica Pharmaceuticals Recent Development
Table 84. Sanofi Company Detail
Table 85. Sanofi Business Overview
Table 86. Sanofi Onychomycosis Product
Table 87. Sanofi Revenue in Onychomycosis Business (2017-2022) & (US$ Million)
Table 88. Sanofi Recent Development
Table 89. Novartis Company Detail
Table 90. Novartis Business Overview
Table 91. Novartis Onychomycosis Product
Table 92. Novartis Revenue in Onychomycosis Business (2017-2022) & (US$ Million)
Table 93. Novartis Recent Development
Table 94. Research Programs/Design for This Report
Table 95. Key Data Information from Secondary Sources
Table 96. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Onychomycosis Market Share by Type: 2021 VS 2028
Figure 2. Distal Subungual Onychomycosis Features
Figure 3. White Superficial Onychomycosis Features
Figure 4. Proximal Subungual Onychomycosis Features
Figure 5. Candida Onychomycosis Features
Figure 6. Others Features
Figure 7. Global Onychomycosis Market Share by Application in 2021 & 2028
Figure 8. Hospital Pharmacies Case Studies
Figure 9. Retail Pharmacies Case Studies
Figure 10. Others Case Studies
Figure 11. Onychomycosis Report Years Considered
Figure 12. Global Onychomycosis Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 13. Global Onychomycosis Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 14. Global Onychomycosis Market Share by Region: 2021 VS 2028
Figure 15. Global Onychomycosis Market Share by Players in 2021
Figure 16. Global Top Onychomycosis Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Onychomycosis as of 2021)
Figure 17. The Top 10 and 5 Players Market Share by Onychomycosis Revenue in 2021
Figure 18. North America Onychomycosis Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 19. North America Onychomycosis Market Share by Country (2017-2028)
Figure 20. United States Onychomycosis Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. Canada Onychomycosis Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. Europe Onychomycosis Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. Europe Onychomycosis Market Share by Country (2017-2028)
Figure 24. Germany Onychomycosis Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. France Onychomycosis Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. U.K. Onychomycosis Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Italy Onychomycosis Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Russia Onychomycosis Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Nordic Countries Onychomycosis Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Asia-Pacific Onychomycosis Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Asia-Pacific Onychomycosis Market Share by Region (2017-2028)
Figure 32. China Onychomycosis Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Japan Onychomycosis Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. South Korea Onychomycosis Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Southeast Asia Onychomycosis Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. India Onychomycosis Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Australia Onychomycosis Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Latin America Onychomycosis Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Latin America Onychomycosis Market Share by Country (2017-2028)
Figure 40. Mexico Onychomycosis Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Brazil Onychomycosis Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Middle East & Africa Onychomycosis Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Middle East & Africa Onychomycosis Market Share by Country (2017-2028)
Figure 44. Turkey Onychomycosis Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 45. Saudi Arabia Onychomycosis Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 46. Abbott Laboratories Revenue Growth Rate in Onychomycosis Business (2017-2022)
Figure 47. Glaxosmithkline Revenue Growth Rate in Onychomycosis Business (2017-2022)
Figure 48. Pfizer Revenue Growth Rate in Onychomycosis Business (2017-2022)
Figure 49. Bausch Health Revenue Growth Rate in Onychomycosis Business (2017-2022)
Figure 50. Galderma Revenue Growth Rate in Onychomycosis Business (2017-2022)
Figure 51. Janssen Biotech Revenue Growth Rate in Onychomycosis Business (2017-2022)
Figure 52. Bristol Meyer Squibb Revenue Growth Rate in Onychomycosis Business (2017-2022)
Figure 53. Topica Pharmaceuticals Revenue Growth Rate in Onychomycosis Business (2017-2022)
Figure 54. Sanofi Revenue Growth Rate in Onychomycosis Business (2017-2022)
Figure 55. Novartis Revenue Growth Rate in Onychomycosis Business (2017-2022)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Abbott Laboratories Glaxosmithkline Pfizer Bausch Health Galderma Janssen Biotech Bristol Meyer Squibb Topica Pharmaceuticals Sanofi Novartis